Download
|
< Back |
| 01:20 PM | |
| Solara Active Pharma Sciences Limited has informed the Exchange regarding interalia, to consider and approve the audited Standalone and Consolidated Financial Results for the year ended March 31, 2026, and unaudited Financial Results for the quarter ended March 31, 2026, alongwith the Auditor''s report for the said period. | |
| View all announcements for Solara Active Pharma Sciences Ltd | Source: BSE India |